Navigation Links
ARKRAY's GLUCOCARD® Vital and 01 Blood Glucose Meters are now on the Department of Defense Uniform Formulary.
Date:10/28/2011

EDINA, Minn., Oct. 28, 2011 /PRNewswire/ -- ARKRAY USA, Inc. (ARKRAY) announced today that the GLUCOCARD® Vital and 01 are now listed on the Department of Defense (DoD) Uniform Formulary.  The DoD Pharmacy and Therapeutic committee (P&T) selected both the GLUCOCARD® Vital and the GLUCOCARD® 01 Blood Glucose Meters as the first and second most cost effective blood glucose meters in all points of service as noted by the Uniform Formulary Beneficiary Advisory Panel (BAP) earlier this year.

Both GLUCOCARD Vital and GLUCOCARD 01 meter systems feature advanced auto coding technology and require only a tiny sample size at a cost that is less than other blood glucose meter systems on the Uniform Formulary including the current blood glucose meter offered on the Basic Core Formulary.  

"We're excited that ARKRAY has two meters on the Department of Defense Uniform Formulary," said Jonathan Chapman, President of ARKRAY. "Our GLUCOCARD meter systems offer high performance standards.  To be recognized by the DoD for having the most cost-effective blood glucose meters is an honor."

GLUCOCARD meters work with ARK Care™, a Real-Time Diabetes Data Management System.  This unique, patient focused, online software for diabetes management allows patients, healthcare providers and care givers to capture data, see results, and manage ones diabetes. Every GLUCOCARD meter is backed by our GLUCOCARD YouChoose® Wellness and Support Program. Exclusively for GLUCOCARD patients, the program provides free education and support materials, recipes, meal planners, ongoing support, and more.  

ARKRAY will be demonstrating their GLUCOCARD Blood Glucose Meters at the Joint Forces Pharmacy Seminar (JFPS) in Dallas, TX next week.  "Exhibiting at the largest annual event for the military pharmacy community is the perfect opportunity to show pharmacists and technicians first hand how our products perform for their patients with diabetes," said Robert Wernsman, Vice President of Consumer Healthcare Division.

About ARKRAY

ARKRAY has been a pioneer for over 50 years in the field of automated analysis from laboratory and point-of-care systems to home use patient self testing systems. ARKRAY invests heavily in R&D and has a strong commitment to high-quality products. ARKRAY is the company that developed the world's commercially successful portable blood glucose analyzer in the early 1970s and the world's first A1C analyzer in 1982.


'/>"/>
SOURCE ARKRAY USA, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vitala™ Pouchless Continence Control Device Shown to be Safe and Effective for up to 12 Hours in Phase 3 Clinical Trial
2. BD to Increase Access to Vital Cervical Cancer Screening in Resource-Limited Settings Through Commitment to Pink Ribbon Red Ribbon Initiative®
3. SAIC Completes Acquisition of Vitalize Consulting Solutions, Inc.
4. ConvaTec Presents New Data on ConvaTec Moldable Technology™ and Vitala™ Continence Control Device in Ostomy Care
5. Recall of Infant and Neonatal-Sized FilterLine H Set and VitaLine H Set Sampling Lines
6. AT&T Connected Vitality GlowCaps Wins 2011 Global Mobile Award
7. Vitalitec Acquires ENCLOSE II Anastomosis Assist Device
8. Dr. F. Stockmans, One of the Earliest Proponents of Materialises Surgicase(R) Orthopaedics, States the Case for its Vital Role in the Treatment of Distal Radius Malunions at ASSH 2010
9. FUJIFILM Revitalizes Images of Health Breast Cancer Awareness Initiative
10. Honoring Those Who Collect Blood, Medicines Most Vital Natural Resource
11. Detailed Cholesterol Test Provides Vital Clues for Women in Search of PCOS Answers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Feb. 11, 2016  Ampio Pharmaceuticals, Inc. (NYSE MKT: ... entered into a Controlled Equity Offering SM Sales ... Michael Macaluso , Chairman and CEO, stated "During ... are not currently raising money and that we have ... 2017 and still complete all of our current objectives ...
(Date:2/11/2016)... Germany , February 11, 2016 ... up 6.8% to EUR 1,377.2m  Adjusted EBITDA climbs to ... 18.0% to EUR 3.41  Proposed dividend of EUR 0.85 ... sale of glass tubing business and refinancing successfully completed  ... to 5% on organic basis  Adjusted EBITDA expected ...
(Date:2/10/2016)... REDWOOD CITY, Calif., Feb. 10, 2016   Genomic Health, Inc. ... progress for the quarter and year ended December 31, 2015. ... in the fourth quarter of 2015, compared with $69.1 million in ... a constant currency basis, revenue increased 9 percent compared with the ... --> U.S. revenue was $63.9 million in the fourth ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... February 11, 2016 , ... ... the American Academy of Dermatology Annual Meeting at the Walter E. Washington Convention ... raise awareness for both the condition of hyperhidrosis (excessive sweating) and its treatment ...
(Date:2/11/2016)... ... 11, 2016 , ... Husted Kicking has completed its Third Annual ... 6th & 7th, 2016 according to kicking coach Michael Husted. , “This event serves ... NFL’s combine in Indianapolis,” says Husted. “The NFL uses a third party organization to ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... The book, ... for IT services, what questions to ask your IT consultant before signing a contract ... to your computer network. , “With companies relying heavily on e-mail and technology, it’s ...
(Date:2/11/2016)... ... , ... As part of their 2015 end of year funding strategy, ... has gifted $10,000 to University of Chicago to support ovarian cancer research being conducted ... are honored to support a promising young investigator from Dr. Lengyel’s lab at the ...
(Date:2/10/2016)... City, California (PRWEB) , ... February 10, 2016 ... ... Imaging Society (WMIS), known as the World Molecular Imaging Congress (WMIC), will be ... theme for the 2016 meeting is “Imaging Biology…Improving Therapy.” The congress will highlight ...
Breaking Medicine News(10 mins):